D.C. Circuit Court Stays Approval Of Pravachol ANDAs
The D.C. Circuit Court of Appeals enjoined FDA from granting final approval to any ANDA for generic versions of Bristol-Myers Squibb's cholesterol therapy Pravachol (pravastatin) April 20
The D.C. Circuit Court of Appeals enjoined FDA from granting final approval to any ANDA for generic versions of Bristol-Myers Squibb's cholesterol therapy Pravachol (pravastatin) April 20